English
Back
Clear
All
Quotes
News
Learn
Help
All
HK
US
CN
SG
AU
JP
All
News
Announcements
Reports
No matches yet
Operations too frequent. Please try again later.
Please check network settings and try again Refresh Refresh
Loading
History record
    Latest News
    Quotes More
    News More
    Learn More
    Help More
    Loading
    News More
    Announcements More
    Reports More
    Help Center Trading Ability Corporate Action Corporate Action Notice SRNE Liquidating Trust Requests Return of Distributed Shares

    SRNE Liquidating Trust Requests Return of Distributed Shares

    Re: Notice to shareholders of Scilex Holding Company (SCLX; ISIN: US80880W1062) and Sorrento Therapeutics, Inc. (SRNE; ISIN: US83587F2020)
     
    Dear Clients,
     
    Following a notification from upstream brokers regarding the Chapter 11 bankruptcy case of SRNE, the U.S. Bankruptcy Court for the Southern District of Texas has issued an order allowing the Liquidating Trust of SRNE (“SRNE Liquidating Trust”) to pursue recovery of SCLX shares distributed to certain shareholders (“Affected Shareholders”).
     
    The SRNE Liquidating Trust believes that the distribution of SCLX common stock to shareholders of SRNE around 19/01/2023, constitutes a fraudulent transfer and therefore should be avoided. SRNE has proposed a settlement (“Settlement Offer”) to the Affected Shareholders, whereby for every 2 shares of SCLX stock received, the shareholders must return 1 share. In return for the returned SCLX shares, the Affected Shareholders will receive compensation of $2 per share or a subordinated unsecured claim against the SRNE Liquidating Trust. If the Affected Shareholders do not accept the settlement, SRNE may initiate legal action to recover all SCLX shares distributed to them.
     
    For details, please refer to official information: SRNE Liquidating Trust Requests Return of Distributed Shares

    Corporate Action Encyclopedia

    Please seek independent legal advice and liaise directly with the SRNE Liquidating Trust directly for discussions. The contact details of the SRNE Liquidating Trust and its legal advisor are:
     
    Liquidating Trustee of the Sorrento Therapeutics, Inc.et al.,
    Liquidating Trust
    David Weinhoffer
    3560 Old Spanish Trl,
    Houston, Texas 77021
    Email: SorrentoTrust@macco.group
    with a copy to
    Norton Rose Fulbright US LLP
    Attn. Ryan E. Manns
    2200 Ross Avenue, Suite 3600,
    Dallas, Texas 75201
     
    Due to reasons on our upstream brokers, our company will not submit the settlement agreement on your behalf. Please sign the settlement agreement in the official information yourself and send it to the SRNE Liquidation Trust. We accept no responsibility for your actions or inactions. Thank you.
     
    Best regards,
     
    Futu Securities International (Hong Kong) Limited